| Literature DB >> 28380424 |
Peng Chen1, Zhen-Lan Du2,3,4, Yuan Zhang1, Bing Liu1, Zhi Guo1, Jin-Xing Lou1, Xue-Peng He1, Hui-Ren Chen1.
Abstract
AIMS: To investigate the association of several single nucleotide polymorphisms (SNPs) within vascular endothelial growth factor (VEGF) and vitamin D receptor (VDR) gene polymorphisms and additional gene- gene and gene- smoking interaction with multiple myeloma (MM) risk in Chinese population.Entities:
Keywords: interaction; multiple myeloma; smoking; vascular endothelial growth factor; vitamin D receptor
Mesh:
Substances:
Year: 2017 PMID: 28380424 PMCID: PMC5482672 DOI: 10.18632/oncotarget.16510
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
General characteristics of 1388 study participants in case and control group
| Variables | Case group(n=460) | Control group(n=928) | |
|---|---|---|---|
| Age (year) (Means± SD) | 62.6±14.5 | 61.9±15.8 | 0.425 |
| Males, N (%) | 248 (53.9) | 485 (52.3) | 0.562 |
| Smokers, N (%) | 201 (43.7) | 257 (27.7) | <0.001 |
| Alcohol drinkers, N (%) | 139 (30.2) | 246 (26.5) | 0.146 |
| BMI (kg/m2) (Means± SD) | 23.1±9.8 | 24.6±9.2 | 0.005 |
| Family history of MM N (%) | 43 (9.3) | ||
| Staging | |||
| DS I–II | 108 (23.5) | ||
| DS III | 352 (76.5) | ||
| ISS I–II | 276 (60.0) | ||
| ISS III | 184 (40.0) | ||
| Percentage of bone marrow plasma cells (range) | 35 (14–93) | ||
| Creatinine in mg/dl (range) | 1.7 (0.5–6.1) | ||
| C-reactive protein in mg/dl (range) | 0.6 (0.1–15.8) |
Genotype and allele frequencies of 6 SNPs between case and control group
| SNP | Genotypes andAlleles | Frequencies N (%) | OR(95%CI)* | HWE test forcontrols | |
|---|---|---|---|---|---|
| Control (n=928) | Case (n=460) | ||||
| VEGF gene | |||||
| rs2010963(+405 G>C) | |||||
| Co-dominant | |||||
| GG | 542(58.4) | 241 (52.4) | 1.00 (ref) | 0.935 | |
| GC | 335(36.1) | 181 (39.3) | 1.28(0.83-1.87) | ||
| CC | 51(5.5) | 38 (8.3) | 1.51(0.79-2.34) | ||
| Dominant | |||||
| GG | 542(58.4) | 241 (52.4) | 1.00 (ref) | ||
| GC+CC | 386(41.6) | 219(47.6) | 1.36(0.81-1.96) | ||
| Allele, C (%) | 437(23.5) | 257(27.9) | |||
| rs699947(2578 C>A) | |||||
| Co-dominant | |||||
| CC | 598(64.4) | 229(49.8) | 1.00 (ref) | 0.108 | |
| CA | 284(30.6) | 175(38.0) | 1.36(1.08-1.72) | ||
| AA | 46 (5.0) | 56(12.2) | 2.38(1.59-3.17) | ||
| Dominant | |||||
| CC | 598(64.4) | 229(49.8) | 1.00 (ref) | ||
| CA+AA | 330(35.6) | 231(50.2) | 1.72(1.19-2.33) | ||
| Allele, A (%) | 376(20.3) | 287(31.2) | |||
| rs833061(460 C>T) | |||||
| Co-dominant | |||||
| CC | 532(57.3) | 236 (51.3) | 1.00 (ref) | 0.105 | |
| CT | 329(35.5) | 177(38.5) | 1.24 (0.81-1.80) | ||
| TT | 67 (7.2) | 47(10.2) | 1.48 (0.86-2.13) | ||
| Dominant | |||||
| CC | 532(57.3) | 236 (51.3) | 1.00 (ref) | ||
| CT+TT | 396(42.7) | 224(48.7) | 1.30(0.83-1.91) | ||
| Allele, T (%) | 463(25.0) | 271(29.5) | |||
| VDR gene | |||||
| ApaI (rs7975232) | |||||
| Co-dominant | |||||
| GG | 537(57.9) | 238 (51.7) | 1.00 (ref) | 0.288 | |
| GT | 330(35.6) | 175 (38.1) | 1.24(0.81-1.83) | ||
| TT | 61(6.6) | 47 (10.2) | 1.57(0.75-2.40) | ||
| Dominant | |||||
| GG | 537(57.9) | 238 (51.7) | 1.00 (ref) | ||
| GT+TT | 391(42.1) | 222(48.3) | 1.26(0.79-1.99) | ||
| Allele, T (%) | 452(24.4) | 269(29.2) | |||
| FokI (rs2228570) | |||||
| Co-dominant | |||||
| CC | 607 (65.4) | 237 (51.5) | 1.00 (ref) | 0.234 | |
| CT | 280 (30.2) | 181 (39.3) | 1.47 (1.22-1.85) | ||
| TT | 41 (4.4) | 42 (9.2) | 2.12 (1.43-2.88) | ||
| Dominant | |||||
| CC | 607 (65.4) | 237 (51.5) | 1.00 (ref) | ||
| CT+TT | 321 (34.6) | 223 (48.5) | 1.68 (1.26-2.17) | ||
| Allele, T (%) | 362 (19.5) | 265 (28.8) | |||
| BsmI (rs1544410) | |||||
| Co-dominant | |||||
| AA | 590 (63.6) | 259(56.3) | 1.00 (ref) | ||
| AG | 290 (31.2) | 161 (35.0) | 1.32 (0.92-1.81) | ||
| GG | 48 (5.2) | 40 (8.7) | 1.52 (0.83-2.35) | ||
| Dominant | |||||
| AA | 590 (63.6) | 259(56.3) | 1.00 (ref) | ||
| AG+GG | 338 (36.4) | 201 (43.7) | 1.38 (0.90-1.87) | ||
| Allele, G (%) | 386 (20.8) | 241 (26.2) | |||
* Adjusted for gender, age, smoking and alcohol status, BMI and WC.
GMDR analysis on the best gene–gene and gene- smoking interaction models
| Locus no. | Best combination | Cross-validationconsistency | Testingaccuracy | |
|---|---|---|---|---|
| Gene- gene interactions* | ||||
| 2 | rs699947 rs2228570 | 9/10 | 0.6072 | 0.0010 |
| 3 | rs699947 rs2228570 rs2010963 | 8/10 | 0.5399 | 0.1719 |
| 4 | rs699947 rs2228570 rs2010963 rs1544410 | 7/10 | 0.5399 | 0.3770 |
| 5 | rs699947 rs2228570 rs2010963 rs1544410 rs833061 | 6/10 | 0.4958 | 0.4258 |
| 6 | rs699947 rs2228570 rs2010963 rs1544410 rs833061 rs7975232 | 5/10 | 0.4958 | 0.6230 |
| Gene- smoking interactions * | ||||
| 2 | rs2228570 Smoking | 10/10 | 0.6011 | 0.0107 |
| 3 | rs2228570 rs699947 Smoking | 9/10 | 0.5399 | 0.1719 |
| 4 | rs2228570 rs699947 rs2010963 Smoking | 8/10 | 0.4958 | 0.3770 |
| 5 | rs2228570 rs699947 rs2010963 rs1544410 Smoking | 7/10 | 0.4958 | 0.4258 |
| 6 | rs2228570 rs699947 rs2010963 rs1544410 rs833061 | 6/10 | 0.4958 | 0.6230 |
| 7 | rs2228570 rs699947 rs2010963 rs1544410 rs833061 rs7975232 Smoking | 5/10 | 0.4958 | 0.9893 |
* Adjusted for gender, age, smoking, drinking and BMI for gene- gene interaction analysis
**Adjusted for gender, age, drinking and BMI for gene- smoking interaction analysis
Analysis for gene-gene and gene- smoking interaction by using logistic regression
| Variable 1 | Variable 2 | OR (95% CI)* | |
|---|---|---|---|
| rs699947 | rs2228570 | ||
| CC | CC | 1.00 | - |
| CA+AA | CC | 1.48 (1.14 -1.92) | 0.001 |
| CC | CT+TT | 1.38 (1.05-1.79) | 0.032 |
| CA+AA | CT+TT | 3.12 (1.82 -4.61) | <0.001 |
| rs2228570 | Smoking | ||
| CC | Never | 1.00 | - |
| CT+TT | Never | 1.35(1.04 -1.82) | 0.038 |
| CC | Current | 1.56 (1.17-2.01) | 0.002 |
| CT+TT | Current | 3.27 (1.74-4.86) | <0.001 |
* Adjusted for gender, age, drinking and BMI
Description and probe sequence for 6 SNPs used for PCR analysis
| SNP ID | Chromosome | FunctionalConsequence | Restrictionenzyme | Nucleotidesubstitution | Primer sequences |
|---|---|---|---|---|---|
| rs2010963+405 G>C | 6:43770613 | Upstream variant 2KB, utr variant 5 prime | FaqI | G > C | F:5′-TTGCTTGCCATTCCCCA CTTGA-3′R: 5′-CCGAAGCGAGAACAGC CCAGA-3′ |
| rs833061460 C>T | 6:43769749 | Upstream variant 2KB | HinpI | C>T | F:5′-TGAGTGTGTGCGTGTGGG GTTGAGCG-3′R: 5′-AGAGCCGTTCCCTCTTT GCTAG-3′ |
| rs6999472578 C>A | 6:43768652 | Upstream variant 2KB | BstyI | C>A | F:5′-GGCCTTAGGACACCATACC-3′R: 5′-CACAGCTTCTCCCCTATCC-3′ |
| FokI (rs2228570) | 12:47879112 | Missense | FokI | C>T | Forward: GCACTGACTCTGGC TCTGACReverse: ACCCTCCTGCTCCT GTGGCT |
| BsmI (rs1544410) | 12:47846052 | Intron variant, upstream variant 2KB | FspI | A>G | Forward: GGAGACACAGATAA GGAAATACReverse: CCGCAAGAAACCTCAA ATAACA |
| ApaI (rs7975232) | 12:47845054 | Intron variant, upstream variant 2KB | ApaI | G>T | Forward: TGGGCACGGGGATAG AGAAGReverse: ACGGAGAAGTCACTG GAGGG |